Location
United States, North America
Cheque size
$2M - $50M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
Pharmaceuticals
About Investor
Matthew McAviney is a Partner at New Enterprise Associates (NEA). He focuses on healthcare and biopharma, with activity spanning Seed and Series A (and some Series B), and his stated investment range is $2.0M – $50.0M. His background includes being a Principal at F-Prime Capital and earlier roles at Oliver Wyman and in finance.
Previous investments
Ouro Medicines
120M |2025
AviadoBio
78M |2021
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,AL
Alicia Lenis
Canada, North America
$500K - $2M
Pre Seed
,Seed
,FB
Frank Balas
Canada, North America
$100K - $5M
Pre Seed
,Seed
,NP
Neil Peet
Canada, North America
$500K - $2M
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.